Ronald H M A Bartels1, Godard de Ruiter1, Ton Feuth1, Mark P Arts1. 1. Department of Neurosurgery, Radboud University Medical Center, Nijmegen, Netherlands (R.H.M.A.B.); Department of Neurosurgery, The Haaglanden Medical Center, The Hague, Netherlands (G.d.R., M.P.A.); Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands (T.F.).
Abstract
BACKGROUND: The treatment of spinal epidural metastasis is multidisciplinary and usually involves a team of medical oncologists, radiologists, radiotherapists, and spinal surgeons. Life expectancy is one of the factors considered when deciding whether surgery is warranted. Because expert estimates of life expectancy are generally not reliable, a prediction model is needed. Here, we temporally validated a model that was previously validated geographically. METHODS: The records of 110 consecutive patients who were referred with a spinal epidural metastasis were collected prospectively from 2009 to 2013 in order to validate the model, which was published in 2011. The actual and estimated life expectancies were represented graphically, and calibration and discrimination were determined. The calibration slope, Harrell's c-index, D, and R2D were calculated. Hazard ratios in the derivation set of 2011 were compared with the validation set. Misspecification was determined using the joint test for β*. RESULTS: The calibration slope was 0.64 ± 0.15 (95% CI: 0.34-0.94), Harrell's c-index was 0.72, D was 1.08, and R2D was 0.22, indicating slightly worse discrimination in the derivation set. The joint test for β* = 0 was statistically significant and indicated misspecification; however, this misspecification was attributed entirely to the surgical group. CONCLUSIONS: We validated a prediction model for surgical decision making, showing that the model's overall performance is good. Based on these results, this model will help clinicians to decide whether to offer surgery to patients with spinal epidural metastasis.
BACKGROUND: The treatment of spinal epidural metastasis is multidisciplinary and usually involves a team of medical oncologists, radiologists, radiotherapists, and spinal surgeons. Life expectancy is one of the factors considered when deciding whether surgery is warranted. Because expert estimates of life expectancy are generally not reliable, a prediction model is needed. Here, we temporally validated a model that was previously validated geographically. METHODS: The records of 110 consecutive patients who were referred with a spinal epidural metastasis were collected prospectively from 2009 to 2013 in order to validate the model, which was published in 2011. The actual and estimated life expectancies were represented graphically, and calibration and discrimination were determined. The calibration slope, Harrell's c-index, D, and R2D were calculated. Hazard ratios in the derivation set of 2011 were compared with the validation set. Misspecification was determined using the joint test for β*. RESULTS: The calibration slope was 0.64 ± 0.15 (95% CI: 0.34-0.94), Harrell's c-index was 0.72, D was 1.08, and R2D was 0.22, indicating slightly worse discrimination in the derivation set. The joint test for β* = 0 was statistically significant and indicated misspecification; however, this misspecification was attributed entirely to the surgical group. CONCLUSIONS: We validated a prediction model for surgical decision making, showing that the model's overall performance is good. Based on these results, this model will help clinicians to decide whether to offer surgery to patients with spinal epidural metastasis.
Authors: Roy A Patchell; Phillip A Tibbs; William F Regine; Richard Payne; Stephen Saris; Richard J Kryscio; Mohammed Mohiuddin; Byron Young Journal: Lancet Date: 2005 Aug 20-26 Impact factor: 79.321
Authors: Ronald H M A Bartels; Ton Feuth; Dirk Rades; Rune Hedlund; Carlos Villas; Yvette van der Linden; Wolgang Börm; Arnoud Kappelle; Richard W M van der Maazen; J André Grotenhuis; André L M Verbeek Journal: Cancer Metastasis Rev Date: 2011-06 Impact factor: 9.264
Authors: Yvette M van der Linden; Sander P D S Dijkstra; Ernest J A Vonk; Corrie A M Marijnen; Jan Willem H Leer Journal: Cancer Date: 2005-01-15 Impact factor: 6.860
Authors: Edward Chow; Lori Davis; Tony Panzarella; Charles Hayter; Ewa Szumacher; Andrew Loblaw; Rebecca Wong; Cyril Danjoux Journal: Int J Radiat Oncol Biol Phys Date: 2005-03-01 Impact factor: 7.038
Authors: N A Quraishi; S R Manoharan; G Arealis; A Khurana; S Elsayed; K L Edwards; B M Boszczyk Journal: Eur Spine J Date: 2013-01-18 Impact factor: 3.134
Authors: Laurens Bollen; Yvette M van der Linden; Willem Pondaag; Marta Fiocco; Bas P M Pattynama; Corrie A M Marijnen; Rob G H H Nelissen; Wilco C Peul; P D Sander Dijkstra Journal: Neuro Oncol Date: 2014-07 Impact factor: 12.300
Authors: Kunal Bhanot; Jessica Widdifield; Anjie Huang; J Michael Paterson; David B Shultz; Joel Finkelstein Journal: Can J Surg Date: 2022-08-04 Impact factor: 2.840